Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
Novartis has submitted a request in Delaware federal court urging the judge who oversaw a December patent litigation trial to issue a final decision and verdict on the case before July 15. If it gets its way, Novartis could block generic rival MSN from launching its Entresto copycat until late next year.
Novartis has submitted a request in Delaware federal court urging the judge who oversaw a December patent litigation trial to issue a final decision and verdict on the case before July 15. If it gets its way, Novartis could block generic rival MSN from launching its Entresto copycat until late next year.
